INFUSYSTEM HOLDINGS, INC Unrealized Gain (Loss) on Derivatives
INFUSYSTEM HOLDINGS, INC (INFU) reported Unrealized Gain (Loss) on Derivatives of $83.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2013-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2013-03-28
- INFUSYSTEM HOLDINGS, INC unrealized gain (loss) on derivatives for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC unrealized gain (loss) on derivatives for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC unrealized gain (loss) on derivatives for the quarter ending 2011-06-30 was $83.00K.
- INFUSYSTEM HOLDINGS, INC unrealized gain (loss) on derivatives for the quarter ending 2010-12-31 was $417.00K.
- INFUSYSTEM HOLDINGS, INC unrealized gain (loss) on derivatives for fiscal 2011 was $83.00K, a 59.90% decline from fiscal 2010.
- INFUSYSTEM HOLDINGS, INC unrealized gain (loss) on derivatives for fiscal 2010 was $207.00K.
- INFUSYSTEM HOLDINGS, INC unrealized gain (loss) on derivatives for fiscal 2009 was -$78.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $0.00 derived: sum of 2 quarters · filed 2013-03-28 | $83.00K derived: sum of 3 quarters · filed 2013-03-28 | $83.00K 10-K · filed 2013-03-28 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $83.00K derived: sum of 2 quarters · filed 2012-11-14 | $83.00K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $83.00K 10-Q · filed 2012-08-08 | $83.00K 10-Q · filed 2012-08-08 | ||
| 2010-12-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $667.00K derived: sum of 2 quarters · filed 2012-03-16 | $596.00K derived: sum of 3 quarters · filed 2012-03-16 | $207.00K 10-K · filed 2012-03-16 |
| 2010-09-30 | $250.00K 10-Q · filed 2011-11-14 | $179.00K derived: sum of 2 quarters · filed 2011-11-14 | -$210.00K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | -$71.00K 10-Q · filed 2011-08-15 | -$460.00K 10-Q · filed 2011-08-15 | ||
| 2009-12-31 | -$78.00K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |